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ABSTRACT
The pharmacokinetic profi le of ceftriaxone was studied in healthy and febrile Black Bengal goats after 
its single intramuscular administration at the dose rate of 50 mg/kg body mass. The fever was induced by 
intravenous administration of E. coli serovar O126:B8 lipopolysaccharide (1 μg/kg, IV) and the plasma drug 
concentration was analyzed using HPLC. The plasma drug concentration versus time curve best fi tted the two 
compartment open model. At 1 min the ceftriaxone concentrations in healthy and febrile animals were 40.58 ± 
0.94 μg/mL and 32.83 ± 0.92 μg/mL, respectively and the drug could be detected up to 8 h in healthy goats and 
up to 4 h in febrile goats. The elimination half-life of ceftriaxone in febrile animals (0.95 ± 0.02 h) was lower 
than healthy animals (2.30 ± 0.19 h). Volume of distribution was higher in febrile animals (0.72 ± 0.01 L/kg) 
in comparison to healthy animals (0.15 ± 0.07 L/kg). Total body clearances in healthy and febrile animals were 
5.08 ± 0.14 and 8.82 ± 0.31 mL/kg/h, respectively, suggesting extensive clearance of the drug in febrile animals. 
The intramuscular dose of ceftriaxone in febrile animals was calculated as 6 mg/ kg body mass, to be repeated at 
a 6 h interval. Results of the present study indicated that the drug distribution is altered by fever. 
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Introduction 
Ceftriaxone (CTX) is a third generation cephalosporin used extensively in veterinary 
clinical practice because of its broad spectrum antibacterial activity, low toxicity and 
resistance to enzyme β-Lactamases (ANGEHRN et al., 1980; CLEELAND and SQUIRES, 
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1984). This drug has high potential application in septicemia, bacteremia, lower respiratory 
tract infection, urinary tract infection, peritonitis, enteritis and soft tissue infections, 
because of its excellent penetration into the extra vascular space (PATEL and KAPLAN, 
1984; TAN et al., 1984). 
The pharmacokinetics of different antimicrobials are reported to vary during different 
disease conditions (BURROW, 1985; FRAZIER et al., 1988). Likewise, the kinetic profi le 
of CTX varies with animal species, disease conditions and route of drug administration 
(SAR et al., 2006; GOUDAH, 2008). Fever is the most important clinical manifestation of 
many infectious diseases in goats and is reported to induce biochemical and physiological 
alterations in cells (VAN MIERT, 1987; LOHUIS et al., 1988). The pharmacokinetic profi le 
of many drugs changes during fever (WILSON et al., 1984; CHAUDHARY et al., 1999). 
Despite the great potential for clinical use in veterinary medicine, the effect of fever on 
the pharmacokinetics of CTX after intramuscular administration in goats has not been 
studied so far. Therefore, the present study aimed to determine the pharmacokinetics of 
CTX in Black-Bengal goats following its intramuscular administration.
Materials and methods
The study was conducted on ten healthy, female Black Bengal goats, 1.5 to 2 years 
old, weighing 12-14 kg. The goats were kept under observation and periodical clinical 
examination for two weeks before commencing the experiment to exclude the possibility 
of any disease. They were maintained on balanced ration, green fodder and dry grass, and 
water was provided ad libitum. The experiment was conducted as per the guidelines of the 
Institutional Animal Ethics Committee.
Animals were randomly divided into two equal groups. Group I served as the afebrile 
healthy goat model, while group II served as the febrile goat model. Ceftriaxone sodium 
(WOCEF 3 g) was obtained from Wockhart Pvt. Ltd, Mumbai, India. Acetonitrile and 
Methanol (HPLC grade), N-acetyl-N, N- trimethyl ammonium bromide, sodium citrate, 
dibasic potassium phosphate (KH2PO4) and monobasic potassium phosphate (K2HPO4) 
were procured from Loba chemical Ltd., Mumbai, India and Ranbaxy fi ne chemical Ltd., 
New Delhi, India. A single intramuscular injection of ceftriaxone sodium at the dose rate 
of 50 mg/kg body mass was administered in the gluteal muscles of each experimental 
animal. Rectal temperature was recorded prior to drug administration and thereafter at 
hourly intervals. About 2 mL of blood sample was collected in separate heparinized vials 
by jugular vein puncture at an interval of 0.08, 0.16, 0.25, 0.33, 0.50, 0.75, 1, 2, 3, 4, 6 and 
8 h after drug administration. The plasma was separated by centrifugation at 3000 rpm 
for 10 minutes and stored at -20 °C until drug analysis. Fever was induced by intravenous 
administration of E. coli serotype 0126:B8 lipopolysaccharide (LPS) at the rate of 0.2 μg/
kg body mass. After 5 hours, half of the initial LPS dose was repeated for maintenance 
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of the fever up to 12 hours. A single dose of CTX at the rate of 50 mg/kg body mass 
was injected intramuscularly after an hour of LPS administration. Blood samples were 
collected in the heparinized vials after 0.08, 0.16, 0.25, 0.33, 0.50, 0.75, 1, 2, 3, 4, 6 and 
8 h of drug administration and plasma was separated. The CTX concentrations in plasma 
samples were estimated by High Performance Liquid Chromatography (HPLC) assay 
(SAR et al., 2006). The HPLC system, Cecil 4100 (Cecil Instrumentation, Cambridge), UV 
detector and column RPC-18 were used. The mobile phase consisted of acetonitrile and 
water (40:60) and tetraheptyl ammonium bromide (0.32 per cent) as ion pairing agent. 
The concentration of CTX was scanned at 280 nm wave length. The mobile phase was 
pumped through a column at a fl ow rate of 1.0 mL/min, at an ambient temperature of 350 
C. The sample (20 μL) was injected into HPLC with the help of 25 μL loop of Hamilton 
syringe. In the present study, the LOD (limit of detection) value of CTX in the plasms 
by HPLC was 3.66 μg/mL, whereas the LOQ (limit of quantifi cation) value was 2.50 
μg/mL. The inter and intra assay variations were 6.5 and 5.7% respectively. Various 
pharmacokinetic parameters were determined by computerized software programming 
‘Pharmakit’, J. I. P. M. E. R., Ponducherry, India. Different pharmacokinetic parameters 
were statistically analyzed by the standard method (SNEDECOR and COCHRAN, 2004).
The intramuscular dose rate (mg/kg body mass) and the dose interval (h) of CTX in 
febrile goats were estimated using the kinetic data (SHARGEL and ANDREW, 1985):
Cpmax/Cp min = 1/e-
β.r 
Where; r = interval for dose repeat; β = Overall elimination rate constant; Cpmax = 
(Dose/Vd)/1-e-β.r; Cpmax and Cp min are maximum and minimum concentrations of drug 
respectively in plasma.
Results
The plasma CTX concentrations in healthy and febrile goats were plotted on semi-
logarithmic scale (Fig. 1). In the group I animals, rectal temperature varied within the 
normal range during the entire experimental period. In group II animals, a rise in rectal 
temperature (39.2 - 40.4 0C) was observed one hour after the LPS administration, and 
remained elevated up to 12 hours. The drug concentration in plasma could be detected 
for up to 8 hours in healthy goats and up to 4 hours in febrile goats. Evaluation of the 
drug concentration data revealed that the pharmacokinetics of CTX was best described 
by a two- compartment open model. Initially, during the distribution phase, a rapid fall 
in plasma drug concentration was observed. Thereafter, it gradually declined during the 
elimination phase to reach a level below the detection limit after 6 hours. The various 
pharmacokinetic parameters of CTX in healthy and febrile goats are summarized in Table 
1. In febrile goats A, C0P, α, β, ClB
 and Vd area were signifi cantly (P<0.05) higher, while 
t½α, t½β, AUC and MRT were signifi cantly (P<0.05) lower in comparison to healthy goats. 
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Table 1. Pharmacokinetic profi le of ceftriaxone following a single intramuscular administration in 
healthy and febrile goats






(Febrile goats) P value
A (μg/mL) 48.18 ± 0.40 69.54 ± 2.58 0.001
B (μg/mL) 50.54 ± 5.60 73.26 ± 1.16 0.014
Cop (μg/mL) 43.81 ± 0.75 60.44 ± 1.20 0.000
α (h-1) 4.96 ± 0.22 15.99 ± 0.51 0.000
β (h-1) 0.30 ± 0.02 0.73 ± 0.01 0.000
t1/2α (h) 0.14 ± 0.00 0.03 ± 0.00 0.000
t1/2β (h) 2.30 ± 0.19 0.95 ± 0.02 0.002
AUC(mg/L.h) 163.40 ± 5.43 90.01 ± 8.80 0.001
MRT (h) 3.27 ± 0.10 1.34 ± 0.04 0.000
ClB(ml/kg/min) 5.08 ± 0.14 8.82 ± 0.31 0.000
Vdarea (L/kg) 0.15 ± 0.07 0.72 ± 0.01 0.020
A = Zero time intercept of distribution phase; B = Zero time intercept of elimination phase; α = Distribution /
absorption rate constant; β = Elimination rate constant; t½α = Distribution/absorption half life; t½β = Elimination 
half life; Vd area = Apparent volume of distribution; ClB = Total body clearance, AUC = Total area under the time 
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Discussion 
The peak plasma CTX concentration (45.98 ± 0.92 μg/mL) was observed at 0.75 
h after its intramuscular administration in healthy goats. Likewise, in buffalo calves, 
peak plasma concentration of CTX was also observed 0.5 h after its intramuscular 
administration (GOHIL et al., 2009). The high value of the distribution rate constant (α) 
15.99 ± 0.51 h-1 in febrile animals indicated that CTX is rapidly distributed into various 
body fl uid and tissue compartments. This may be due to increased capillary permeability, 
caused by different chemical mediators released during the fever (YANG and LEE, 2008). 
The pharmacokinetics of CTX best fi tted in the two compartment open model, after its 
intramuscular administration (KUMAR et al., 2010). 
In accord with the present fi nding, PAWAR and SHARMA (2008) reported higher 
value of cefepime in the B (zero time intercept of elimination phase) than the A (zero 
time intercept of distribution ) phase in cross- bred calves. In febrile goats, the half-
life of the distribution phase and the half-life of the elimination phase were lower in 
comparison to healthy goats, suggesting rapid clearance of the drug in febrile animals. 
The lower elimination half-life of CTX in febrile female goats was supported by the 
fi ndings of ISMAIL (2005a) who reported lower elimination half-life of cefepime in cross 
bred calves. This difference in elimination half-life could be due to differences in the 
age, sex and breed of the animals. The elimination half-life of CTX had been reported as 
1.76 h in ewes (ISMAIL, 2005b) and 2.1 h in horses (GUGLICK et al., 1998). Hyperthermia 
causes alterations in renal function (MUSTAFA et al., 2007). Tachycardia and increased 
total cardiac output may be the possible reasons behind increased renal perfusion and 
glomerular fi ltration (RULE et al., 2000), enhancing rapid elimination of the drug. 
The volume of distribution (Vdarea) for CTX in febrile goats was higher than the 
reported value of Vdarea in horses (0.225 L/kg) (GUGLICK et al., 1998). The high value of 
Vd area in female goats suggested that CTX is distributed principally through extracellular 
fl uid space. In concurrence with the results of the present study, an increase in Vd area in 
febrile animals was also reported for other cephalosporin antibiotics including cefuroxime 
(CHAUDHARY et al., 1999) and cefotaxime (SHARMA et al., 2006). In the present study the 
AUC was higher in healthy animals. DARDI et al. (2005) also reported higher AUC for 
CTX in healthy buffalo calves in comparison to febrile animals. Similarly, a decrease in 
AUC following intramuscular administration of cefazolin in febrile goats was reported 
by ROY et al. (1994). 
It was found that the value of ClB in febrile animals was signifi cantly (P<0.05) higher 
as compared to healthy animals. However, the value of ClB as calculated in the present 
study was less than the values reported in foals, cow calves and dogs. The value of ClB 
reported in foals, dog (GARDNER and PAPICH, 2001) and cow calves (ISMAIL, 2005a) 
was 78, 129.6, and 66 mL.kg.-1, respectively. Contrary to the present fi ndings JOSHI and 
SHARMA (2007) reported that ClB does not differ signifi cantly during fever. 
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Fever, one of the most common manifestations of many infectious diseases, is 
reported to change the heart rate and renal, hepatic and splanchnic blood fl ow (KASTING 
et al., 1982).Fever is also associated with signifi cant alterations in hepatic function, leading 
to changes in levels of various enzymes responsible for the metabolism of antimicrobials. 
Therefore, elimination and biotransformation patterns of antimicrobials may change 
during fever (SINGH et al., 1997). Changes in the permeability of the biological membrane 
barrier and/or tissue and plasma pH during fever may cause alteration in the distribution 
pattern of different drugs. These changes may be more important in patients suffering from 
encephalitis, infectious prostitis, arthritis and mastitis. For example, certain antibiotics 
may quickly attain high concentration in joint fl uid during endotoxin induced synovial 
infl ammation (FIRTH et al., 1988). 
Calculation of a suitable dosage regimen of CTX in febrile goats, on the basis of 
pharmacokinetic parameters, was another objective of the present study. A minimum 
therapeutic plasma CTX concentration of 1.0 μg/mL has been shown to be effective 
against most gram positive as well as gram negative bacteria. For example, MIC90 of 
CTX for Salmonella, Escherichia coli and Pasteurella multocida isolated from calves 
was found to be 0.03-0.2 μg/mL (SOBACK and ZIV, 1988). 
From the data obtained from the present study, it may be concluded that the 
pharmacokinetics of CTX changes during fever in goats. CTX can be recommended to 
be given by intramuscular route at the dose rate of 6 mg/ kg body mass every 6 hours in 
febrile goats.
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SAŽETAK
Istraživana je farmakokinetika ceftriaksona u zdravih i febrilnih crnih bengalskih koza nakon njegove 
jednokratne intramuskularne primjene u dozi od 50 mg/kg tjelesne mase. Vrućica je bila prouzročena 
intravenskom primjenom lipopolisaharida (1 μg/kg) serovara O126:B8 bakterije E. coli. Koncentracija lijeka u 
plazmi bila je određivana tekućinskom visokotlačnom kromatografi jom. Koncentracija lijeka u plazmi u odnosu 
na vremensku krivulju najviše je odgovarala modelu dvaju otvorenih odjeljaka. Koncentracija ceftriaksona u 
zdravih životinja nakon minute bila je 40,58 ± 0,94 μg/mL, a u febrilnih 32,83 ± 0,92 μg/mL. Lijek se nakon 
primjene mogao dokazati do osam sati u zdravih te do 4 sata u febrilnih koza. Poluživot izlučivanja ceftriaksona 
u febrilnih koza bio je manji (0,95 ± 0,02 h) nego u zdravih (2,30 ± 0,19 h). Obujam raspodjele bio je veći (0,72 
± 0,01 L/kg) u febrilnih u usporedbi sa zdravima (0,15 ± 0,07 L/kg). Ukupan tjelesni klirens u zdravih životinja 
bio je 5,08 ± 0,14, a u bolesnih 8,82 ± 0,31 mL/kg/h što upućuje na ekstenzivan klirens lijeka u febrilnih 
životinja. Izračunato je da intramuskularna doza ceftriaksona u febrilnih životinja iznosi 6 mg/kg tjelesne mase 
svakih 6 sati. Rezultati istraživanja upućuju na zaključak da se raspodjela lijeka mijenja kod vrućice.
Ključne riječi: ceftriakson, doziranje, vrućica, koza, farmakokinetika________________________________________________________________________________________
